Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Plos One|January 23, 2009
Metabolomic profiling of drug responses in acute myeloid leukaemia cell linesStefano Tiziani, Alessia Lodi, Farhat L Khanim, et al.
Cancer Research|December 21, 2010
Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic cloneAndrew J Lilly, Farhat L Khanim, Rachel E Hayden, et al.
Chempluschem|January 24, 2020
Tracer-Based Metabolic NMR-Based Flux Analysis in a Leukaemia Cell LineJohn B Carrigan, Michelle A C Reed, Christian Ludwig, et al.
Chempluschem|June 28, 2016
Tracer-Based Metabolic NMR-Based Flux Analysis in a Leukaemia Cell LineJohn B Carrigan, Michelle A C Reed, Christian Ludwig, et al.
Scientific Reports|February 23, 2019
A framework for tracer-based metabolism in mammalian cells by NMRRaquel Saborano, Zuhal Eraslan, Jennie Roberts, et al.
ACS Chemical Biology|October 5, 2010
Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulationAlessia Lodi, Stefano Tiziani, Farhat L Khanim, et al.
The Journal of Biological Chemistry|May 19, 2006
Slug regulates integrin expression and cell proliferation in human epidermal keratinocytesFrances E Turner, Simon Broad, Farhat L Khanim, et al.
Plos One|February 23, 2013
Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active diseaseAlessia Lodi, Stefano Tiziani, Farhat L Khanim, et al.
Bioscience Reports|December 8, 2020
Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cellsJonathan J Sheard, Andrew D Southam, Hannah L MacKay, et al.
British Journal of Haematology|January 14, 2010
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)Jim A Murray, Farhat L Khanim, Rachel E Hayden, et al.
Pageof 4